荣昌生物:第一季度净利润为3.28亿元,同比扭亏为盈

老虎资讯综合
Apr 28

4月28日,荣昌生物公告称,2026年第一季度实现营业收入6.56亿元,同比增长24.76%;归属于上市公司股东的净利润为3.28亿元,同比扭亏为盈。业绩变动主要系商业化产品销售收入持续增加,以及产品技术授权导致研发投入减少,认股权证公允价值变动所致。


Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10